Continuum Advisory, LLC Spring Works Therapeutics, Inc. Transaction History
Continuum Advisory, LLC
- $660 Million
- Q1 2024
A detailed history of Continuum Advisory, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 97 shares of SWTX stock, worth $3,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97Holding current value
$3,566% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
235Shares Held
67.7MCall Options Held
546KPut Options Held
29.4K-
Vanguard Group Inc Valley Forge, PA6.53MShares$240 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.44MShares$200 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.11MShares$151 Million0.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.48MShares$128 Million5.66% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$126 Million8.76% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.29B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...